Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study Meeting Abstract


Authors: Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; Murphy, C.; Wang, J.; Noble, E.; Esteves, B.; Method, M.; Coleman, R.
Abstract Title: Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study
Meeting Title: 2022 Society of Gynecologic Oncology Annual Meeting
Journal Title: Gynecologic Oncology
Volume: 166
Issue: Suppl. 1
Meeting Dates: 2022 Mar 18-21
Meeting Location: Phoenix, AZ
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2022-08-01
Start Page: S50
Language: English
ACCESSION: WOS:000892325300081
PROVIDER: wos
DOI: 10.1016/S0090-8258(22)01297-5
Notes: Meeting Abstract: LBA 4 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason Konner
    156 Konner